… improve and strengthen the modest changes that we made in the last Democratic Congress to negotiate drug prices. And what was it like? I think only 50 drugs per year. We were going to do modest and it' it's not only the number but the restrictions that were put on that so that when a new drug launches, it can launch it as high a price as it wants even under that bill and only after years can you do something about it. There are many different things that need to be fixed, one of which is to expand the number of drugs. Yeah, I know. (21:21–21:40)
CLAIM
Asserts that current legislation allows new drugs to launch at high prices with delayed regulation.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
